HomeELAN • NYSE
add
Elanco Animal Health Inc
Previous close
$12.94
Day range
$12.80 - $13.01
Year range
$8.02 - $18.80
Market cap
6.42B USD
Avg Volume
6.97M
P/E ratio
17.27
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 1.19B | -1.00% |
Operating expense | 563.00M | 1.08% |
Net income | 67.00M | 109.38% |
Net profit margin | 5.62 | 111.28% |
Earnings per share | 0.37 | 8.82% |
EBITDA | 282.00M | -5.69% |
Effective tax rate | -11.67% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 487.00M | 41.16% |
Total assets | 12.94B | -7.69% |
Total liabilities | 6.59B | -17.27% |
Total equity | 6.35B | — |
Shares outstanding | 496.65M | — |
Price to book | 1.01 | — |
Return on assets | 2.37% | — |
Return on capital | 2.84% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 67.00M | 109.38% |
Cash from operations | -4.00M | -300.00% |
Cash from investing | -58.00M | -256.76% |
Cash from financing | 52.00M | 292.59% |
Net change in cash | 19.00M | 371.43% |
Free cash flow | -59.38M | 86.26% |
About
Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world. Wikipedia
Founded
1954
Website
Employees
9,225
